01952.HK
Everest Medicines Limited
HKSE · Healthcare · Biotechnology · CN
HKD 27.58
+4.71%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 23.40x
- P/E 2027E
- 22.49x
- P/E 2028E
- 9.00x
- P/S forward
- 4.07x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.52x
- Price / sales
- 3.30x
- Price / cash flow
- -43.23x
Enterprise value
- Enterprise value
- HKD 9.2B
- EV / sales
- 3.28x
- EV / EBITDA
- 203.23x
- EV / EBIT
- -61.74x
- Market cap
- HKD 9.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026